Rafael Amado – Biography
Last update: May 22, 2026Executive profile
Rafael was Executive Vice President, Head of R&D and Chief medical Officer at Allogene Therapeutics, and President, Research & Development at Adaptimmune. Rafael Amado joined ZAI Lab in 2025.
Rafael Amado is currentlyPresident and Head of Global Oncology R&D & Global R&D at ZAI Lab - View - ZAI Lab org chart
Director at Synnovation Therapeutics - View - Synnovation Therapeutics org chart
Create your alert
to follow the career of Rafael Amado.
Education
Rafael Amado has a Doctor of Medicine in Hematology and Oncology from University of California, Los Angeles.
They have also studied at University of California, Los Angeles :
Find more alumni from University of California, Los Angeles
More about Rafael Amado
Do you need to know more about Rafael Amado? More results.
Participate
Social media
- Rafael Amado on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Rafael Amado
The colleagues of Rafael Amado
Company Colleagues
- At ZAI Lab, Rafael Amado has 31 colleagues including Samantha Du (CEO & Chairman), John Diekman (Director)…
- At Synnovation Therapeutics, Rafael Amado has 17 colleagues including Wenqing Yao (CEO & Director), Ting Feng (Director)…
Homonyms
- Rafaela Amador - Chief Public Affairs and Communications Officer - Tampa Bay Rays
Industry Colleagues
- In the Biotechnology industry, Rafael Amado has 35,920 colleagues in 2,423 companies located in 43 countries. 17,184 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Rafael Amado.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Rafael Amado.
